L’immunothérapie adoptive des tumeurs solides enfin réhabilitée

Francine Jotereau; Nathalie Labarrière; Nadine Gervois; Marie-Christine Pandolfino; Brigitte Dreno

doi:10.1051/medsci/2003193268

Accueil

Tous les numéros

Volume 19 / Numéro 3 (Mars 2003)

Med Sci (Paris), 19 3 (2003) 268-270

Références

Accès gratuit

Numéro		Med Sci (Paris) Volume 19, Numéro 3, Mars 2003


Page(s)		268 - 270
Section		Le Magazine : Nouvelles
DOI		https://doi.org/10.1051/medsci/2003193268
Publié en ligne		15 mars 2003

Rosenberg S, Packard B, Aebershold P, et al. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. N Engl J Med 1988; 319: 1676–80. [Google Scholar]
Dudley M, Wunderlich P, Robbins P, et al. Cancer regression and autoimmunity following clonal repopulation with anti-tumor lymphocytes and non-myeloablative conditioning. Science 2002; 298: 850–4. [Google Scholar]
Yee C, Thompson J, Byrd D, et al. Adoptive T cell therapy using antigen specific CD8⁺ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration and anti-tumor effect of transferred T cells. Proc Natl Acad Sci USA 2002; 99: 16168–73. [Google Scholar]
Labarrière N, Pandolfino MC, Gervois N, et al. Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients. Cancer Immunol Immunother 2002; 51: 532–8. [Google Scholar]
Dreno B, Nguyen J, Khammari A, et al. Randomized trial of adoptive transfer of melanoma tumor infiltrating lymphocytes as adjuvant therapy for stage III melanoma. Cancer Immunol Immunother 2002; 51: 539–46. [Google Scholar]
North R. Cyclophosphamidefacilitated adoptive immunotherapy of an established tumor depends on elimination of tumorinduced sppressor T cells. J Exp Med 1982; 55: 1063–74. [Google Scholar]
Dudley M, Wunderlich J, Yang J, et al. A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma. J Immunother 2002; 25: 243–51. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.

[1] Rosenberg S, Packard B, Aebershold P, et al. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. N Engl J Med 1988; 319: 1676–80. [Google Scholar]

[2] Dudley M, Wunderlich P, Robbins P, et al. Cancer regression and autoimmunity following clonal repopulation with anti-tumor lymphocytes and non-myeloablative conditioning. Science 2002; 298: 850–4. [Google Scholar]

[3] Yee C, Thompson J, Byrd D, et al. Adoptive T cell therapy using antigen specific CD8⁺ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration and anti-tumor effect of transferred T cells. Proc Natl Acad Sci USA 2002; 99: 16168–73. [Google Scholar]

[4] Labarrière N, Pandolfino MC, Gervois N, et al. Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients. Cancer Immunol Immunother 2002; 51: 532–8. [Google Scholar]

[5] Dreno B, Nguyen J, Khammari A, et al. Randomized trial of adoptive transfer of melanoma tumor infiltrating lymphocytes as adjuvant therapy for stage III melanoma. Cancer Immunol Immunother 2002; 51: 539–46. [Google Scholar]

[6] North R. Cyclophosphamidefacilitated adoptive immunotherapy of an established tumor depends on elimination of tumorinduced sppressor T cells. J Exp Med 1982; 55: 1063–74. [Google Scholar]

[7] Dudley M, Wunderlich J, Yang J, et al. A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma. J Immunother 2002; 25: 243–51. [Google Scholar]